A Study on Maampattai Kudineer (Internal) for the management of Maantha Kazhichal(Infectious Diarrhoea) in Pediatric Age Group

Pre-Clinical and Clinical Evaluation of the Efficacy of Maampattai Kudineer in the Management of Maantha Kazhichal (Infectious Diarrhoea) through Oral Administration in Pediatric Age Group - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103708

Enrollment

Registered

2026-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: MAAMPATTAI KUDINEER: Dosage: 10 30 ml twice daily before food (age-adjusted) Duration: 14 days Route: Oral administration Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: Age: 3-12 years Sex: Both male and female children Diarrhoea Normal or Mild Malnourished status. Mild and Moderate dehydration Abdominal pain

Exclusion criteria

Exclusion criteria: Children younger than 3 years or older than 12 years. Chronic Gastrointestinal diseases or other chronic illness (Ulcerative Colitis, Celiac disease, Malena) Signs of severe dehydration which requires immediate hospitalization. Children with viral diarrhoea (e.g., Rotavirus, Adenovirus). Dysentery with blood/mucus in stools suggestive of Shigella or amoebiasis. Children already on antibiotics or anti-diarrhoeal medications for current illness. Parents or Guardians unwilling for the study.

Design outcomes

Primary

Measure	Time frame
This study will help to understand the effects of MAAMPATTAI KUDINEER in the management of MAANTHA KAZHICHAL (INFECTIOUS DIARRHOEA) and may provide a better improvement in health care of children.Timepoint: The study outcomes will be assessed at predefined time points, namely at baseline (Day 0), during treatment (Day 7), and at the end of treatment (Day 14), to evaluate the effects of Maampattai Kudineer in the management of Maantha Kazhichal (infectious diarrhoea) and its impact on improving the health status of children.	—

Measure

Time frame

This study will help to understand the effects of MAAMPATTAI KUDINEER in the management of MAANTHA KAZHICHAL (INFECTIOUS DIARRHOEA) and may provide a better improvement in health care of children.Timepoint: The study outcomes will be assessed at predefined time points, namely at baseline (Day 0), during treatment (Day 7), and at the end of treatment (Day 14), to evaluate the effects of Maampattai Kudineer in the management of Maantha Kazhichal (infectious diarrhoea) and its impact on improving the health status of children.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr T MAHARASI MANISELVI MD S

Government Siddha Medical college and Hospital, Palayamkottai - 627002

selvimaharasi@gmail.com8903181693

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026